Current knowledge and concepts of immunity to syphilis have been well summarized by Tumer (12) .
Although man possesses little or no innate immunity to syphilis, he develops a substantial degree of acquired immunity to the disease. Immunity is acquired slowly, possibly because the protective immunogen is weak, and wanes after elimination of the organism either naturally or by antibiotic therapy. Despite many years of extensive investigation, nothing definitive is known about the mechanisms involved in acquired immunity or the identity of the protective immunogen(s). There are no compelling reasons to rule out the potential contribution of either humoral or cellular immune forces to total immunity. The demonstration of "protective antibodies" in the serum of infected rabbits by Eberson (1) and of treponema immobilizing (TPI) antibody by Nelson and Mayer (7) initially supported the concept that immunity to syphilis is due solely to humoral antibodies. However, the later finding that there is no certain correlation between the serum titers of TPI antibody and immunity (4) and the evidence that strong delayed hypersensitivity to treponeme antigens develops in the course of disease have led a number of investigators to suggest that immunity in syphilis is primarily cellular in nature. Although phagocytosis of live treponemes is not known to occur, it is possible that cellular immune forces could operate in other ways than by destruction within phagocytes, such as by the direct effects of lymphokines (8) or through the agency of cytophilic antibodies on "immune cells."
The experimental approach of determining the infectivity of virulent organisms mixed with immune serum, initially employed by nikoff and Roux (5), in 1905, has been used by most subsequent investigators. This is unfortunate because the in vitro susceptibility of Treponema pallidum to TPI antibody appears to be an in vitro aging artifact resulting from progressive loss of the surface mucoid layer (uncoating) which is presumed to afford the treponeme in vivo protection against antibody (6, 12) . The most obvious approach for determining the mechanisms of acquired immunity to syphilis would be to attempt to transfer resistance passively with large doses of immune serum or cells or combinations thereof. Since a perusal of the literature did not reveal that trials of this sort had been made, the present experiments with immune serum were performed.
MATERIALS AND METHODS New Zealand male rabbits weighing from 1.5 to 3.0 kg were used. They were subjected to serological screening for T. cuniculi infection by the VDRL and FIA tests and were caged individually in a room in which the ambient temperature did not exceed 70 F (21 C). They were maintained on an antibiotic-free diet. The inoculum was prepared from a uniform suspension of T. pallidum (Nichols strain) stored in liquid nitrogen, and consisted of motile organisms that were resistant to the immediate immobilizing effect of TPI antibody and complement and, hence, must have possessed intact mucoid coats. The suspending medium was TPI medium containing 10% dimethylsulfoxide and 10% normal rabbit serum. Chancres were produced by inoculating 106 T. pallidum intracutaneously (i.c.) at each of six sites on the shaved back. The number of organisms in the suspension used for inoculation was determined by spreading 5 gliters of the material under a cover slip (22 by 22 mm) rimed with vaseline. The number of organisms was calculated by counting 50 high-power darkfields and multiplying the total by 106.
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Since there is a tendency for the individual chancres to vary considerably in size, every effort was made to achieve uniformity of inoculation with respect to depth of injection into the skin and numbers of organisms deposited at each injection site. Attention was paid to keeping organisms well suspended, charging syringes but once, randomizing sites injected on the same and different animals in experimental and control groups, etc. After inoculation, the animals were observed daily for the appearance of chancres; the mean diameter of induration and character of the lesions were recorded, and darkfield tests were done periodically on a representative chancre. At most sites, beginning chancres were evident by day 3.
Normal pooled serum was prepared from blood specimens obtained by intracardiac aspiration. A pool of hyperimmune serum (immune serum) was prepared, in a similar manner, from rabbits that had been inoculated i.c. with the standard dose of T. pallidum every 3 months until they were strongly resistant to skin reinfection (usually 3 to 6 months). The immune sera were collected 5 days after the last challenge dose of T. pallidum; they were titrated for VDRL, FTA and TPI antibodies and were pooled; the titers were as follows: VDRL, 1:64; TPI, 1:256; and FITA, 1: 2048. All pooled sera were subjected to membrane filtration (0.45 ,sm; Millipore Corp.) prior to storage without preservative at -20 C.
RESULTS
Varying doses of pooled immune rabbit serum were first tested for their capacity to alter the course of early chancres. Control rabbits consisted of untreated animals and animals given normal pooled serum. Skin lesions were established in 16 animals with the standard inoculum of 106 T. pallidum. Twenty-four hours after chancres first appeared on each animal (i.e., on day 4 or 5), a dose of 80 ml of hyperimmune serum per kg body weight was administered intraperitoneally (i.p.) to each of eight of the animals (Fig. 1) . Controls consisted of four animals given normal serum and four animals not given serum. The chancres in both the immune serum-treated and control animals increased progressively in size from small papules at day 3 after treponeme inoculation, to large, intensely indurated, elevated, darkfieldpositive lesions between 10 and 15 mm in diameter by day 10. However, after day 10, the chancres in the animals given immune serum receded, and most of them were inconspicuous between weeks 3 and 4. Because of the small numbers of organisms persisting in the lesions, prolonged search was often necessary to demonstrate treponemes by darkfield examination of the exudates obtained by scraping the injection sites. The inconspicuous lesions in these animals were in sharp contrast to the large chancres in control animals, which continued to progress for some time after day 8 to become necrotic and teeming with organisms. The difference in the size and character of the chancres of immune serum-treated and control rabbits was most apparent between weeks 3 and 4 of the experiment (Fig. 2) . Between weeks 4 and 5, the lesions in six of the eight immune serum-treated rabbits began to enlarge and to develop induration, whereas the chancres of control rabbits started to resolve and heal. The subsequent course and character of these resurgent chancres in the immune serum-treated animals were similar to the course of the chancres in the control animals earlier in the experiment.
Initial attempts to prevent or to delay the onset of chancres in rabbits by giving a high i.p. dose of the same pool of immune serum (80 ml/kg) 24 h prior to inoculation of the standard dose of 106 T. pallidum were not successful. Although in these experiments the onset times of chancres did not differ in immune serumtreated and control animals, the chancres in treated animals did not attain sizes as large as the chancres in control animals and were not as Although the manner by which antibodies may act is unknown, it is possible that they serve to immobilize the organisms and/or to destroy them when combined with complement. Reynolds (9) observed that treponemes inoculated into the subcutaneous tissues of immune rabbits did not disseminate from the site of inoculation, whereas in nonimmune rabbits the organisms entered the regional lymphatics within minutes and were rapidly disseminated via the draining lymph nodes and blood stream. The promptness of this localizing effect in the immune animal suggests that the immune forces involved were humoral rather than cellular. Our observation that early chancres, initially suppressed by immune serum, later ran the normal cycle of development and healing seen in control animals, implies that the effect of immune serum was primarily that of preventing an increase in numbers of organisms; at least its effect was not one of killing all or perhaps even the majority of organisms present when the serum was given. This suggests that multiplying organisms are the principal targets of humoral antibodies in vivo.
